Screener
Oruka Therapeutics, Inc. ORKA Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
FAQ
- What is Oruka Therapeutics, Inc.'s invested capital?
- Oruka Therapeutics, Inc. (ORKA) reported invested capital of $439.01M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s invested capital changed year-over-year?
- Oruka Therapeutics, Inc.'s invested capital increased by 55.6% year-over-year, from $282.1M to $439.01M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s invested capital has grown at a 189.5% compound annual growth rate (CAGR), from -$2.1M to $426.93M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Oruka Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude